Inactief instrument

Andere talen Kalytera Therapeutics Inc Toronto S.E.

Aandelen

CA48349P1036

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107	18-08-21
Claritas Pharmaceuticals : IIROC Trading Resumption - CLAS	18-08-21
Claritas Announces Proposed Financing with Obsidian Global GP, LLC, Receipt of Australian Tax Credit, and Start of Phase 1 Clinical Study of R-107	18-08-21
Claritas Pharmaceuticals : IIROC Trading Halt - CLAS	18-08-21
Claritas Announces Grant of Stock Options to Directors and Officers	28-07-21
Claritas Pharmaceuticals : Cites Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe COVID-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107	26-07-21
Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107	26-07-21
Claritas Pharmaceuticals : Reports Additional Data in Animal Model of Pulmonary Arterial Hypertension Treatment, R-107	21-07-21
Claritas Pharmaceuticals, Inc. Announces Additional Data in Validated Animal Model of PAH Demonstrating Ability of R-107 to Prevent, Treat, and Reverse Established Disease	21-07-21
Claritas Announces Additional Data in Validated Animal Model of PAH Demonstrating Ability of R-107 to Prevent, Treat, and Reverse Established Disease	21-07-21
Claritas Pharmaceuticals : 1-For-20 Share Consolidation Effective July 23	20-07-21
Claritas Announces Effective Date for Share Consolidation	20-07-21
Claritas Pharmaceuticals, Inc.(TSXV:CLAS) dropped from S&P/TSX Venture Composite Index	19-07-21
Claritas Pharmaceuticals : Announces Commitments from Company's Largest Shareholders to Vote for Approval of Share Consolidation	11-06-21
Claritas Announces Commitments from Company’s Largest Shareholders to Vote for Approval of Share Consolidation	10-06-21
Claritas Announces Transfer of GVHD Program and Cancellation of Related Debt as Company Focuses on Nitric Oxide Therapeutics	01-06-21
Claritas Pharmaceuticals : Announces Settlement of Debt Transaction	31-05-21
Claritas Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	28-05-21
Claritas Pharmaceuticals Issues Letter to Shareholders	11-05-21
Claritas Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	30-04-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Kalytera Therapeutics Inc Toronto S.E.

Aandelen

CA48349P1036

Andere talen

Filters